VCs To Participate in Micromet PIPE
Micromet Inc. (Nasdaq: MITI), a -based developer of therapeutic antibodies, has filed to sell $70 million worth of common shares in a PIPE offering. VentureWire reports that Abingworth Management and SV Life Sciences, past venture backers of Micromet, will purchase some of the shares.
31 July 2009•3 mins read
